Scientific Beta confirms the non-eligibility of China A-shares for its indices

Udgivet den 04-04-2019  |  kl. 13:06  |  

 

Scientific Beta confirms the non-eligibility of China A-shares for its indices

Increasing the number of Chinese stocks in an investment universe dedicated to smart beta is not appropriate at this time

Scientific Beta, as a leading smart beta index provider, aims to build and publish equity indices that reflect the current state of the global economy while exhibiting a high level of liquidity, investability and replicability.

The definition and construction of an investable universe are key steps in the construction of every equity portfolio and in equity indexing. Investing in smart beta indices requires investors to have access to solutions where liquidity risk is thoroughly considered, because ultimately the weights of the stocks will not be equivalent to their cap-weighting but will depend on other weighting criteria.

This key driver is the main reason why Scientific Beta will not be adding China A-shares at this point, even if the Chinese authorities have made some progress on important aspects:

In December 2018, Chinese stock exchanges tightened their suspensions rules and conditions in an effort to reduce the number of suspensions.In January 2019, the QFII quota doubled to USD 300bn to meet investment demand from overseas investors and prepare for the partial inclusion of China A-shares in some equity benchmarks.

Scientific Beta has noted these efforts made by the Chinese authorities to further promote the functioning of its stock market and enhance the overall market liquidity. Nevertheless, some accessibility issues, which Scientific Beta considers to be potential liquidity risks, or at least penalising for its clients, remain:

Chinese authorities could lock up foreign investor money in the case of extreme moves. Even with the recent liberalisation of QFII programmes, SAFE retains its power to exercise macro-prudential supervision over the repatriation of capital and may impose temporary restrictions.Limited domestic availability of derivative instruments, in particular index futures, access to which is restricted to approved foreign institutional investors and remains limited in scope. This reduces investor ability to implement hedging strategies and risk management strategies.Foreign-ownership restrictions on China A-shares, set at 30%, could become critical with future inflows. Indeed, buy orders via stock trading links with Hong Kong will be halted if foreign holdings reach 28%, creating liquidity issues. Buying will resume only when the figure falls to 26%.

Ultimately, the precautions taken by cap-weighted index providers, which are often adjustments to the capitalisation of the stocks in the indices, are of little use in protecting the liquidity of non-cap-weighted indices. As far as smart beta indices are concerned, this is why the rules applied to cap-weighted indices and their underlying universes are not appropriate and pose serious risks for investors. Scientific Beta is convinced that the current exposure offered to China through a dedicated Chinese geographic basic block made up of one hundred liquid constituents, which are H-Shares, P chips, Red chips and depositary receipts, all listed on foreign exchanges without trading restrictions, preserves investors from these unnecessary investment risks.

As part of its policy of transferring know-how to the industry, EDHEC-Risk Institute has set up Scientific Beta. Scientific Beta is an original initiative which aims to favour the adoption of the latest advances in smart beta design and implementation by the whole investment industry. Its academic origin provides the foundation for its strategy: offer, in the best economic conditions possible, the smart beta solutions that are most proven scientifically with full transparency of both the methods and the associated risks.
Scientific Beta, 1 George Street, #15-02, Singapore 049145. For further information, please contact: contact@scientificbeta.com, Web: www.scientificbeta.com.

Attachment

Press_release_China_A_shares_2019

\Hugin

Udgivet af: NPinvestordk

Seneste nyheder

12:10 Europa/aktier: Samarbejde med Nvidia løfter Kion - Next stiger på julehandlen
11:44 Matas-topchef: Væksten i de fysiske butikker er den store glædelige overraskelse
11:34 Obligationer/middag: Europæisk inflation gav en krusning i renten
11:31 Aktier/middag: Novo lider fortsat under fedmedata mens Matas er dagens stjerne
11:12 Novo Nordisk får højere anbefaling og kursmål hos Bernstein - aktie dykker
11:10 Demant flyver til tops i C25 efter løftet kursmål fra Carnegie
11:01 Vestas-regnskab kan give stor volatilitet spår Danske Bank
11:00 Europæisk arbejdsløshed var igen 6,3 pct. i november
10:57 Novo Nordisk får højere anbefaling og kursmål hos Bernstein - aktie dykker
10:55 Kion vil optimere varelagre med AI og belønnes med topplacering i Europa
10:39 Nvidia ved CES 2025: Ny grafikkortserie og AI til biler blandt højdepunkterne
09:34 ISS falder efter skuffende vækstal fra fransk rival
09:31 Matas ser bedre 2024/25 efter godt tredje kvartal
09:13 Aktier/åbning: Pres på Novo og Mærsk trækker C25 i rødt - Matas belønnes for opjustering
08:58 Obligationer/åbning: Lille rentefald efter overraskende dyk i fransk inflation
08:54 ISS-rivalen Sodexo fastholder forventninger efter "ventet" blød start på året
08:50 Fransk inflation mindre end ventet i december
08:40 Kinesisk Mærsk-konkurrent er sortlistet i USA - men betydningen nedtones
08:08 Storbank ser Vestas levere over 22 mia. kr. i frie pengestrømme over tre år
08:02 Danmark: Ledigheden holdt niveau i november